Funding characteristics of randomised clinical trials supported by the Swiss National Science Foundation: a retrospective cohort study by Alain Amstutz, Stefan Schandelmaier, Roy Frei, Jakub Surina, Arnav Agarwal, Reem Alturki, Belinda von Niederhäusern, Erik von Elm, Matthias Briel, on behalf of the MAking Randomized Trials Affordable (MARTA) Group

Get full text